MTX-439

· Mediar Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MTX-439, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease [Phase 1]